FDA Authorizes First At-Home Sample Collection Test for COVID-19

April 21, 2020 by Dan McCue
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. (NIAID-RML via AP)

WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.

The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.

The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.

Before gaining access to the home test, people are screened using an online questionnaire.

If authorized by a physician, LabCorp will ship a testing kit to their home.

The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.

The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.

FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”

“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.

“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.

The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.

Health

Trump's Rushmore Trip Draws Real and Figurative Fireworks
Political News
Trump's Rushmore Trip Draws Real and Figurative Fireworks

SIOUX FALLS, S.D. (AP) — President Donald Trump will begin his Independence Day weekend on Friday with a patriotic display of fireworks at Mount Rushmore before a crowd of thousands, but even in a part of the country where many remain supportive of the president, the... Read More

Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore
Health
Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore

BELMAR, N.J. (AP) — As coronavirus-related restrictions are eased and temperatures climb, people are flocking back to the Jersey Shore. And with the July Fourth holiday weekend upon us, that's making some people nervous, particularly given the large crowds that have surfaced at some popular shore... Read More

Democrats Say US Needs to Address Protective Gear Shortage
Health
Democrats Say US Needs to Address Protective Gear Shortage

A congressional committee criticized President Donald Trump’s administration on Thursday for a series of problems in distributing personal protective and testing equipment during the coronavirus pandemic and called on the administration to come up with a better plan. “We need urgent action from the federal government... Read More

From Big Cities to Backyards, July 4 Not Usual Blowout Bash
In The News
From Big Cities to Backyards, July 4 Not Usual Blowout Bash

NEW YORK (AP) — The idea sounds almost un-American. The Fourth of July was always a time for communities to come together, daylong celebrations with patriotic parades in the morning and fireworks finales to cap it off. This year, people are being urged to stay home.... Read More

Fauci Warns US Needs to Reverse COVID-19 Trends
Health
Fauci Warns US Needs to Reverse COVID-19 Trends

WASHINGTON — The nation’s top infectious disease specialist warned Tuesday that the United States could see up to 100,000 new cases per day of the virus that causes COVID-19 if the nation does not take steps to control the pandemic. Anthony Fauci, the director of the... Read More

FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
Health
FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
June 30, 2020
by Dan McCue

WASHINGTON - The U.S. Food and Drug Administration released a series of recommendations Tuesday that it say should help facilitate the timely development of a safe and effective COVID-19 vaccine. The agency said the guidance reflects advice it has been providing over the "past several months"... Read More

News From The Well
scroll top